Linked Life Data

14679097

Source:http://linkedlifedata.com/resource/pubmed/id/14679097

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2003-12-17
pubmed:abstractText
The frequency of autoantibody-positve T2DM patients identified as LADA was shown to be high in T2DM patients from Eastern India. In this study, we measured autoantibodies to GAD65, IA-2, and TTG in T2DM patients from Southern India. Our results show that either GAD65 or IA-2 was present in 30% of T2DM patients (n = 155) and in 3% of controls for GAD65 and 1% of controls for IA-2 (n = 105). TTG-Ab was not increased in T2DM patients compared to controls. Our results suggest that LADA is more frequent in Southern Indians than in European Caucasians, but not as high as in Eastern Indians.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0077-8923
pubmed:author
pubmed:issnType
Print
pubmed:volume
1005
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
387-9
pubmed:dateRevised
2007-10-24
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Autoantibodies to GAD65 and IA-2 antibodies are increased, but not tissue transglutaminase (TTG-Ab) in type 2 diabetes mellitus (T2DM) patients from South India.
pubmed:affiliation
Department of Molecular Medicine, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden. sanjeevi.carani@molmed.ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't